-Amyloid (A) pathology is an essential pathogenic component in Alzheimer's disease (AD). However, the significance of A pathology, including A deposits/oligomers and glial reactions, to neurodegeneration is unclear. In particular, despite the A neurotoxicity indicated by in vitro studies, mouse models with significant A deposition lack robust and progressive loss of forebrain neurons. Such results have fueled the view that A pathology is insufficient for neurodegeneration in vivo. In this study, because monoaminergic (MAergic) neurons show degenerative changes at early stages of AD, we examined whether the APPswe/PS1⌬E9 mouse model recapitulates progressive MAergic neurodegeneration occurring in AD cases. We show that the progression forebrain A deposition in the APPswe/ PS1⌬E9 model is associated with progressive losses of the forebrain MAergic afferents. Significantly, axonal degeneration is associated with significant atrophy of cell bodies and eventually leads to robust loss (ϳ50%) of subcortical MAergic neurons. Degeneration of these neurons occurs without obvious local A or tau pathology at the subcortical sites and precedes the onset of anxiety-associated behavior in the mice. Our results show that a transgenic mouse model of A pathology develops progressive MAergic neurodegeneration occurring in AD cases.